SynAm Vaccine

Blood & Organ Banks · Maryland, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

155 Gibbs St Unit 552, Rockville, Maryla...

Phone Number

(301) 541-3688

Revenue

<$5 Million

Industry

Blood & Organ Banks Business Services Healthcare Services Research & Development
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
2
1
2
1

About SynAm Vaccine

SynAm Vaccine is dedicated to eradicating pneumococcal diseases, including pneumonia, middle ear infections, and meningitis, through the development of the world's first universal vaccine. Their lead vaccine candidate aims to provide universal coverage against all 91 bacteria serotypes, addressing a significant unmet medical need in the market. The company targets healthcare providers and organizations focused on infectious diseases and vaccine development. With a strong management team and notable scientific advisors, SynAm Vaccine is positioned to make a substantial impact in the field of immunization.Explore more
SynAm Vaccine's Social MediaPopular SearchesSynam VaccineSynamvaccineSIC Code 28,283NAICS Code 32,325Show more

SynAm Vaccine Org Chart

PhoneEmail
CC
United States flag for contact location.

Vice President, Business Development

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is SynAm Vaccine your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to SynAm Vaccine

Compare insights from companies similar to SynAm Vaccine, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

SynAm Vaccine

<$5M
11-50
Private
-
-
CC
Carolyn ChenVice President, Business Development
$11M
11-50
Private
-
2004
ON
Oumar NiangHead Manager
$6.5M
11-50
Public
$340.5M
2015
JP
Jason PtacekDirector of Translational Science and Biomarkers
<$5M
1-10
Private
-
-
N/A
<$5M
11-50
Private
-
2001
BK
Brent KreiderPresident, Biomed Valley Discoveries, Inc.
<$5M
1-10
Private
-
-
N/A
1-10
Public
$96.1M
2006
Matt Angel, President & Chief Executive Officer at Tempest Therapeutics
Matt AngelPresident & CEO
Illustration of an envelope

Company Profile Activity

i

Among all Healthcare Services companies

Low Activity

High Activity

Activity Insights

SynAm Vaccine is experiencing very low activity levels compared to other companies in the Healthcare Services sector.

What does this means?

SynAm Vaccine is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about SynAm Vaccine.

SynAm Vaccine Tech Stack

A closer look at the technologies used by SynAm Vaccine

Top Blood & Organ Banks Companies

Frequently Asked Questions Regarding SynAm Vaccine

What is SynAm Vaccine's official website?
SynAm Vaccine's official website is www.synamvaccine.com
What is SynAm Vaccine's Revenue?
SynAm Vaccine's revenue is <$5 Million
What is SynAm Vaccine's SIC code?
SynAm Vaccine's SIC: 28,283
What is SynAm Vaccine's NAICS code?
SynAm Vaccine's NAICS: 32,325
How many employees does SynAm Vaccine have?
SynAm Vaccine has 11-50 employees
What industry does SynAm Vaccine belong to?
SynAm Vaccine is in the industry of: Blood & Organ Banks, Business Services, Healthcare Services
What is SynAm Vaccine competition?
SynAm Vaccine top competitors include: NexusPharma, BioMed Valley Discoveries, Health Horizons, Tempest Therapeutics
What technology does SynAm Vaccine use?
Some of the popular technologies that SynAm Vaccine uses are: Yahoo Small Business Web Hosting, DigiCert
How do I contact SynAm Vaccine?
SynAm Vaccine contact info: Phone number: (301) 541-3688 Website: www.synamvaccine.com
What does SynAm Vaccine do?

SynAm Vaccine is dedicated to eradicating pneumococcal diseases, including pneumonia, middle ear infections, and meningitis, through the development of the world's first universal vaccine. Their lead vaccine candidate aims to provide universal coverage against all 91 bacteria serotypes, addressing a significant unmet medical need in the market. The... company targets healthcare providers and organizations focused on infectious diseases and vaccine development. With a strong management team and notable scientific advisors, SynAm Vaccine is positioned to make a substantial impact in the field of immunization.Read More

What are SynAm Vaccine social media links?
SynAm Vaccine Twitter page
Is SynAm Vaccine a public company?
SynAm Vaccine is private company therefore does not currently have an official ticker symbol
See more information about SynAm Vaccine

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.